TCL Archive In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA October 15, 1982
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008
TCL Archive ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation February 19, 2010
TCL Archive In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’ July 27, 1990
